Wockhardt Ltd: Q3FY17 results
Bhagyashree Vivarekar / 24 Jan 2017
Wockhardt Ltd. reported its results for the quarter ended December 31, 2016 today. The company's total sales for Q3FY17 came in at Rs 995.56 crore, which represents a 6.49 per cent sequential decline and 7.35 per cent YoY decline.
Wockhardt Ltd. reported its results for the quarter ended December 31, 2016 today.
The company's total sales for Q3FY17 came in at Rs 995.56 crore, which represents a 6.49 per cent sequential decline and 7.35 per cent YoY decline.
Its operating loss (EBIT loss) for the quarter amounted to Rs 19.99 crore.
The company reported a net loss figure of Rs 53.91 crore versus net profit of Rs 17 crore in Q2FY17.
The company's stock, which opened for trading at Rs 670 on the BSE, has risen 1.85 per cent, closed for the day around Rs. 682.4.
Wockhardt is a global, pharmaceutical and biotechnology company. The company has 7 hospitals across India. Wockhardt's products comprise of formulations, bio pharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs).
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.